CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer.
Authors
Kwok-Leung Cheung
Ian O Ellis
+12 more
Chun Gong
Andrew R Green
Ui-Soon Khoo
Eric W-F Lam
Paul Lee
Terence KW Lee
Mai-Yee Luk
Sai-Ting Ma
Ellen PS Man
Emad A Rakha
Ho Tsoi
Lai-San Wong
Publication date
4 January 2018
Publisher
Clin Cancer Res
Doi
Cite
Abstract
Purpose: Adjuvant tamoxifen treatment revolutionized the management of estrogen receptor (ER)-positive breast cancers to prevent cancer recurrence; however, drug resistance compromises its clinical efficacy. The mechanisms underlying tamoxifen resistance are not fully understood, and no robust biomarker is available to reliably predict those who will be resistant. Here, we study BQ323636.1, a novel splice variant of the NCOR2 gene, and evaluate its efficacy in predicting tamoxifen resistance in patients with breast cancer.Experimental Design: A monoclonal anti-BQ323636.1 antibody that specifically recognizes the unique epitope of this splice variant was generated for in vitro mechanistic studies and for in vivo analysis by immunohistochemistry on tissue microarrays of two independent cohorts of 358 patients with more than 10 years clinical follow-up data, who had ER-positive primary breast cancer and received adjuvant tamoxifen treatment. An orthotopic mouse model was also used.Results: Overexpression of BQ323636.1 conferred resistance to tamoxifen in both in vitro and in an orthotopic mouse model. Mechanistically, coimmunoprecipitation showed BQ323636.1 could bind to NCOR2 and inhibit the formation of corepressor complex for the suppression of ER signaling. Nuclear BQ3232636.1 overexpression in patients samples was significantly associated with tamoxifen resistance (P = 1.79 × 10-6, sensitivity 52.9%, specificity 72.0%). In tamoxifen-treated patients, nuclear BQ323636.1 overexpression was significantly correlated with cancer metastasis and disease relapse. Nuclear BQ323636.1 was also significantly associated with poorer overall survival (P = 1.13 × 10-4) and disease-specific survival (P = 4.02 × 10-5).Conclusions: These findings demonstrate that BQ323636.1 can be a reliable biomarker to predict tamoxifen resistance in patients with ER-positive breast cancer. Clin Cancer Res; 24(15); 3681-91. ©2018 AACRSee related commentary by Jordan, p. 3480
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Name not available
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.nottingham.ac.uk:4...
Last time updated on 04/01/2018
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1158%2F1078-0432.c...
Last time updated on 28/04/2021
Nottingham ePrints
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.nottingham.ac.uk:4...
Last time updated on 04/01/2018
Nottingham eTheses
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.nottingham.ac.uk:4...
Last time updated on 07/01/2023
Name not available
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.nottingham.ac.uk:4...
Last time updated on 04/01/2018
Sustaining member
Apollo (Cambridge)
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:www.repository.cam.ac.uk:1...
Last time updated on 12/01/2019
Repository@Nottingham
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:nottingham-repository.work...
Last time updated on 08/01/2019
Supporting member
Spiral - Imperial College Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:spiral.imperial.ac.uk:1004...
Last time updated on 23/01/2018